Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Daclahep Daclatasvir 60mg Tablets:
Introducing Daclahep, a powerful antiviral tablet containing 60 mg of Daclatasvir, designed to combat chronic hepatitis C virus (HCV) infection.
Uses of Daclahep Daclatasvir 60mg Tablets:
Daclahep Tablets are used for:
Treating chronic hepatitis C virus (HCV) infection
Achieving sustained virologic response (SVR)
Complementing other antiviral agents in HCV treatment regimens
Benefits of Daclahep Daclatasvir 60mg Tablets:
High efficacy in achieving SVR and curing HCV infection
Potent action against the HCV NS5A protein
Well-tolerated with a favorable safety profile
Convenient oral administration for patient adherence
Mechanism of Action of Daclahep Daclatasvir 60mg Tablets:
Daclatasvir works by inhibiting the nonstructural protein 5A (NS5A) of the hepatitis C virus, which is crucial for viral RNA replication and assembly. This inhibition disrupts the HCV life cycle, leading to a significant reduction in viral load and contributing to the successful treatment and potential cure of HCV infection.